Correction Regarding Option Grant
Vancouver, British Columbia – TheNewswire - October 6, 2022 - Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces the following correction to its news release dated October 3, 2022.
The effective date of the grant of 3,000,000 stock options of the Company announced on October 3, 2022 is October 5, 2022. The expiry date of these options is October 5, 2027.
On Behalf of the Board of Directors
LEXSTON LIFE SCIENCES CORP.
Jagdip Bal Chief Executive Officer
Telephone: (604) 928-8913
Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.